Tango Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
TNGX Nasdaq 2836 www.tangotx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Tango Therapeutics, Inc.

TNGX Stock Dips 5% as Q2 Earnings Miss Estimates on Higher Expenses - Aug 12th, 2026 8:46 am
Tango Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights - Aug 11th, 2026 5:00 am
Tango Therapeutics Announces Executive Chair Transition - Aug 6th, 2026 4:24 pm
4 Biotech Stocks Likely to Outpace Q2 Earnings Estimates - Aug 3rd, 2026 8:34 am
FDA Accepts RVMD's Filing for Daraxonrasib in Pancreatic Cancer - Jul 23rd, 2026 11:10 am
How Much Upside is Left in Tango Therapeutics (TNGX)? Wall Street Analysts Think 49.48% - Jul 22nd, 2026 7:55 am
Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues - Jul 15th, 2026 8:01 am
2 Monster Growth Stocks Analysts Think Can Reach New Highs - Jul 9th, 2026 11:54 am
Tango Therapeutics Rides a New Precision Oncology Trend in 2026 - Jul 2nd, 2026 8:50 am
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026? - Jul 2nd, 2026 8:46 am
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts - Jul 2nd, 2026 8:43 am
This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In. - Jun 26th, 2026 1:38 pm
Tango Therapeutics Appoints Robert Azelby to Board of Directors - Jun 22nd, 2026 2:05 pm
Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD - Jun 11th, 2026 6:23 pm
Is Tango Therapeutics (TNGX) Price Justified After Its 7x Surge In One Year - Jun 10th, 2026 2:10 am
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering - Jun 9th, 2026 8:49 pm
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results - Jun 9th, 2026 10:44 am
Tango Therapeutics stock surges on pancreatic cancer trial data - Jun 9th, 2026 7:31 am